购物车
全部删除
您的购物车当前为空
别名 CID-2011756, CID2011756
CID 2011756 是一种具有抗肿瘤活性的ATP 竞争性广谱PKD 抑制剂,对 PKD1 的IC50值为 3.2 µM,在细胞中对 PKD2 和 PKD3 的IC50值分别为 0.6 和 0.7 µM。


为众多的药物研发团队赋能,
让新药发现更简单!
CID 2011756 是一种具有抗肿瘤活性的ATP 竞争性广谱PKD 抑制剂,对 PKD1 的IC50值为 3.2 µM,在细胞中对 PKD2 和 PKD3 的IC50值分别为 0.6 和 0.7 µM。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 185 | 现货 | |
| 5 mg | ¥ 413 | 现货 | |
| 10 mg | ¥ 619 | 现货 | |
| 25 mg | ¥ 1,070 | 现货 | |
| 50 mg | ¥ 1,650 | 现货 | |
| 100 mg | ¥ 2,480 | 现货 | |
| 200 mg | ¥ 3,660 | 现货 | |
| 1 mL x 10 mM (in DMSO) | ¥ 359 | 现货 |
| 产品描述 | CID 2011756 is an ATP-competitive and specific PKD1 inhibitor. |
| 靶点活性 | PKD3:0.7 μM, PKD1:3.2 μM, PKD2:0.6 μM |
| 激酶实验 | Ub-PLA2 assay: Recombinant enzymes in 20 mM Tris-HCl, pH 8.0, 2 mM CaCl2 and 2 mM β-mercaptoethanol (DUB assay buffer) are preincubated with single doses or dose ranges of PR-619 or P22077 for 30 minutes in a 96 well plate before the addition of Ub-PLA2 and NBD C6-HPC. The liberation of a fluorescent product within the linear range of the assay is monitored at room temperature using a fluorescence plate reader. Vehicle (2%(v/v) DMSO) and 10 mM N-ethylmaleimide are included as controls. Where ≥60% inhibition is observed, EC50 values are determined using a sigmoidal dose response equation. |
| 别名 | CID-2011756, CID2011756 |
| 分子量 | 396.87 |
| 分子式 | C22H21ClN2O3 |
| CAS No. | 638156-11-3 |
| Smiles | Clc1cccc(c1)-c1ccc(o1)C(=O)Nc1ccc(CN2CCOCC2)cc1 |
| 密度 | 1.297 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| 溶解度信息 | DMSO: 15 mg/mL (37.8 mM), Sonication is recommended. | |||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (5.04 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
对于不同动物的给药剂量换算,您也可以参考 更多